نتایج جستجو برای: sildenafil

تعداد نتایج: 3308  

Journal: :Diabetes 2007
Julio E Ayala Deanna P Bracy Brianna M Julien Jeffrey N Rottman Patrick T Fueger David H Wasserman

Stimulation of nitric oxide-cGMP signaling results in vascular relaxation and increased muscle glucose uptake. We show that chronically inhibiting cGMP hydrolysis with the phosphodiesterase-5 inhibitor sildenafil improves energy balance and enhances in vivo insulin action in a mouse model of diet-induced insulin resistance. High-fat-fed mice treated with sildenafil plus L-arginine or sildenafil...

Journal: :Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2009
Christina Kruuse Adam E Hansen Henrik B W Larsson Martin Lauritzen Egill Rostrup

Sildenafil (Viagra), a cyclic guanosine monophosphate-degrading phosphodiesterase 5 inhibitor, induces headache and migraine. Such headache induction may be caused by an increased neuronal excitability, as no concurrent effect on cerebral arteries is found. In 13 healthy females (23+/-3 years, 70.3+/-6.6 kg), the effect of sildenafil on a visual (reversing checkerboard) and a hypercapnic (6% CO...

Journal: :Pharmacological reports : PR 2009
Sadhana Kanoo Shripad B Deshpande

Sildenafil, a drug used in the treatment of erectile dysfunction, is a phosphodiesterase 5A inhibitor that increases cyclic guanosine monophosphate (cGMP) levels. In addition to its vascular actions, sildenafil is also known to alter cardiac functions. This study was undertaken to elucidate the effect of sildenafil on cardiac contractility and the underlying mechanisms. The experiments were con...

2015
Pierangelo Chinello Stefania Cicalini Simona Pichini Roberta Pacifici Massimo Tempestilli Maria P. Cicini Leopoldo P. Pucillo Nicola Petrosillo

Sildenafil and bosentan are increasingly used for the treatment of pulmonary arterial hypertension (PAH) in HIV-infected patients. However, concerns exist about pharmacokinetic interactions among sildenafil, bosentan and antiretroviral drugs, including protease inhibitors (PI). We describe here the case of an HIV-infected patient with PAH, who was co-administered bosentan 125 mg twice daily and...

Journal: :Journal of applied physiology 2006
Andrew R Hsu Kimberly E Barnholt Nicolas K Grundmann Joseph H Lin Stewart W McCallum Anne L Friedlander

Sildenafil causes pulmonary vasodilation, thus potentially reducing impairments of hypoxia-induced pulmonary hypertension on exercise performance at altitude. The purpose of this study was to determine the effects of sildenafil during normoxic and hypoxic exercise. We hypothesized that 1) sildenafil would have no significant effects on normoxic exercise, and 2) sildenafil would improve cardiac ...

Rashidi B Roshangar L, Soleimani Rad J, Soleimani Rad S

Background: Implantation is proceeded by a process referred as adhesion. Adhesion requires maturation of endometrium and blastocyst to confer adherence ability to them. During IVF cycles, endometrial maturation is facilitated by progesterone administrating. Considering vasodilatory effect of Sildenafild, in genital organs, it appears that Sildenafil may have similar effect as progestrone. The a...

Journal: :Asian journal of andrology 2005
Onder Yaman Zafer Tokatli Murat Akand Atilla H Elhan Kadri Anafarta

AIM To determine the effect of sildenafil citrate on the nocturnal penile erections (i.e. time to onset, the duration of erection, and the interval between first and second erections) of healthy young men. METHODS Twenty-two potent men, 23-29 years old, were recruited for the study. All subjects completed three sessions over consecutive nights using the RigiScan monitoring device (Dacomed, Mi...

Journal: :Journal of veterinary internal medicine 2007
Heidi B Kellum Rebecca L Stepien

BACKGROUND Pulmonary hypertension (PH) is a disease condition characterized by abnormally increased pulmonary artery pressures and often is associated with a poor prognosis. Sildenafil is a phosphodiesterase inhibitor that causes pulmonary arterial vasodilation and reduction in pulmonary artery pressures. HYPOTHESIS Treatment with sildenafil will improve echocardiographic determinants of PH i...

Journal: :BMJ 2000
E A Stolk J J Busschbach M Caffa E J Meuleman F F Rutten

OBJECTIVE To compare the cost effectiveness of sildenafil and papaverine-phentolamine injections for treating erectile dysfunction. DESIGN Cost utility analysis comparing treatment with sildenafil (allowing a switch to injection therapy) and treatment with papaverine-phentolamine (no switch allowed). Costs and effects were estimated from the societal perspective. Using time trade-off, a sampl...

Journal: :Pharmacological reports : PR 2007
Subramaniam Uthayathas Senthilkumar S Karuppagounder Bessy M Thrash Kodeeswaran Parameshwaran Vishnu Suppiramaniam Muralikrishnan Dhanasekaran

Sildenafil is a phosphodiesterase-5 (PDE5) inhibitor and is predominantly used in the treatment of erectile dysfunction. While maintaining an excellent safety and tolerability profile in the management of erectile dysfunction, sildenafil also provides a prolonged benefit in various other diseases. Sildenafil has been shown to have a potential therapeutic efficacy for disorders related to the ce...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید